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Central noradrenergic signalling mediates arousal and
facilitates learning through unknown molecular mecha-
nisms. Here, we show that the b2-adrenergic receptor
(b2AR), the trimeric Gs protein, adenylyl cyclase, and
PKA form a signalling complex with the AMPA-type gluta-
mate receptor subunit GluR1, which is linked to the b2AR
through stargazin and PSD-95 and their homologues. Only
GluR1 associated with the b2AR is phosphorylated by PKA
on b2AR stimulation. Peptides that interfere with the b2AR–
GluR1 association prevent this phosphorylation of GluR1.
This phosphorylation increases GluR1 surface expression
at postsynaptic sites and amplitudes of EPSCs and mEPSCs
in prefrontal cortex slices. Assembly of all proteins in-
volved in the classic b2AR–cAMP cascade into a supramo-
lecular signalling complex and thus allows highly localized
and selective regulation of one of its major target proteins.
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Introduction
Although cAMP can in general freely diffuse, it can also be
spatially restricted and exert highly localized actions (e.g.
Levitzki, 1988; Neubig, 1994; Zaccolo and Pozzan, 2002;
Rebois and Hebert, 2003; Fischmeister et al, 2006; Richter
et al, 2008; Dai et al, 2009). Evidence for constitutive
association of G protein-coupled receptors and their down-
stream effectors, the trimeric Gs protein and adenylyl cyclase,
with each other has been established and interactions of such
complexes with downstream targets have been proposed to
form the basis for spatially restricted cAMP signalling
(Levitzki, 1988; Neubig, 1994; Rebois and Hebert, 2003; Dai
et al, 2009). Here, we describe a complex containing the
b2-adrenergic receptor (b2AR), Gs, adenylyl cyclase, PKA,
and the AMPA receptor (AMPAR) GluR1 subunit that allows
highly localized signalling by cAMP in neurons.
A brief period of high activity can permanently enhance
synaptic transmission between neurons in the hippocampus.
This long-term potentiation (LTP) has been a focus of intense
study, as a tractable experimental model for learning and
memory. Current evidence implicates trafficking of AMPARs
to the postsynaptic membrane as the primary mechanism of
LTP expression. AMPARs are tetramers formed by GluR1-4
subunits, with GluR1/2 and GluR2/3 heterotetramers account-
ing for the majority of AMPARs in the hippocampus
(Hollmann and Heinemann, 1994; Wenthold et al, 1996;
Dingledine et al, 1999) and GluR1/2 constituting the function-
ally by far prevailing AMPAR component at postsynaptic sites
under basal conditions (Lu et al, 2009). The GluR1 subunit is
thought to have a special function in initiating the remodelling
associated with increased synaptic expression of AMPARs on
LTP. Phosphorylation of GluR1 by PKA on serine 845 (S845) is
critical for activity-driven accumulation of GluR1 at postsy-
naptic sites (Esteban et al, 2003) and fosters surface expression
of GluR1 (Ehlers, 2000; Swayze et al, 2004; Sun et al, 2005; Oh
et al, 2006; Man et al, 2007). Moreover, GluR1 is physically
associated with PKA and the counteracting phosphatase calci-
neurin/PP2B, optimizing the efficacy of this regulation
(Colledge et al, 2000; Tavalin et al, 2002).
Norepinephrine, released by an extensive network of fibres
originating from the locus coeruleus, supports arousal and
learning under novel and emotionally charged situations
(Cahill et al, 1994; Nielson and Jensen, 1994; Berman and
Dudai, 2001; Strange et al, 2003; Strange and Dolan, 2004;
Minzenberg et al, 2008) and facilitates various forms of LTP
in the dentate gyrus and CA1 region of the hippocampus
(Thomas et al, 1996; Lin et al, 2003; Walling and Harley,
2004; Gelinas and Nguyen, 2005). However, the mole-
cular basis of these noradrenergic actions is unclear.
Norepinephrine acts through aAR and bAR. Stimulation of
the b1AR and b2AR activates Gs, adenylyl cyclase, and PKA.
The b2AR is concentrated at excitatory postsynaptic sites in
pyramidal neurons (Davare et al, 2001). We now show that
GluR1 forms a signalling complex with the b2AR, Gs, and
adenylyl cyclase for highly localized GluR1 phosphorylation,
which promotes surface expression of GluR1 and increases
EPSC and mEPSC amplitudes in cortex.
Results
b2AR and GluR1 colocalize in hippocampal neurons
Double labelling for the b2AR and GluR1 in tissue slices from
adult hippocampus showed prominent colocalization of
Received: 21 January 2009; accepted: 27 October 2009; published
online: 26 November 2009
*Corresponding author: Department of Pharmacology, University of
California, Davis, CA 95616-8636, USA. Tel.: þ 1 319 384 4732;
Fax: þ 1 319 335 8930; E-mail: jwhell@ucdavis.edu
{Deceased.
The EMBO Journal (2010) 29, 482–495 | & 2010 European Molecular Biology Organization | All Rights Reserved 0261-4189/10
www.embojournal.org







immunoreactive puncta (Figure 1A). Most of these puncta
were closely associated with puncta immunoreactive for the
presynaptic marker synaptophysin, suggesting that they
represent bona fide synapses. Quantitative analysis indicates
that 490% of the b2AR puncta associated with synaptophy-
sin were also positive for GluR1 (Figure 1B). Furthermore,
480% of GluR1 puncta associated with synaptophysin were
also immunoreactive for b2AR, implying that the large
majority of GluR1-containing synapses also possess the b2AR.
The precise localization of the b2AR was determined by
post-embedding immunogold labelling in the prefrontal cor-
tex (PFC), which receives especially prominent noradrenergic
innervation (e.g. Minzenberg et al, 2008). A large fraction of
gold label was synaptic, and a large fraction of asymmetric
axospinous synapses were immunopositive (Figure 1C). Gold
particles concentrated over the postsynaptic density close to
the postsynaptic membrane. Particles could also be seen
within spines, in large dendritic shafts, in which they were
typically associated with microtubules and in the cytoplasm
of neuronal somata (data not shown).
After solubilization with Triton X-100 and removal of non-
solubilized material by ultracentrifugation, immunoprecipita-
tion of the b2AR from rat forebrain (Figure 1D) led to co-
immunoprecipitation of GluR1 (Figure 1E). This co-precipita-
tion was specific, as the NMDA-type glutamate receptor
(NMDAR) subunit NR2B, which has an overall structure
and cellular distribution similar to GluR1, did not co-precipi-
tate with the b2AR, and control IgG did not immunoprecipi-
tate GluR1 or the b2AR. In contrast, immunoprecipitation
of the NMDAR–PSD-95 complex (Leonard et al, 1998;
Valtschanoff et al, 2000; Lim et al, 2002, 2003) did not result
in co-precipitation of the b2AR (Figure 1F). We conclude that
the b2AR assembles with GluR1-containing AMPARs, but not
with NMDAR into a molecular complex at synapses.
GluR1 interacts with the b2AR through PSD-95
and stargazin/c2
PSD-95 co-immunoprecipitated with the b2AR from rat brain
extracts (Figure 2A). In vitro pull-down experiments indicate
that this association is mediated by the C-terminus of the
b2AR. The distal end of the b2AR C-terminus (DSPL), which
conforms to a type 1 PDZ domain ligand, binds to the third
PDZ domain of PSD-95 (Figure 2B). Stargazin (or g2) and its
homologues g3, g4, g5, g7, and g8 (TARPs) associate with
AMPARs to promote their surface expression and modulate
their biophysical properties. Stargazin binds with its C-termi-
nus to the first two PDZ domains of PSD-95, and this inter-
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Figure 1 Colocalization and co-immunoprecipitation of b2AR and
GluR1. (A) Rat brain sections were triple-labelled for b2AR (left
panels; green in overlays), GluR1 (centre panels; red), and synap-
tophysin (blue in bottom right panel). GluR1 and b2AR puncta
colocalize with each other (boxes) and associate with synaptophy-
sin puncta (triple overlay, bottom right panel) in the stratum
radiatum of the CA1 area. (B) Quantification of the number of
b2AR, GluR1, or synaptophysin (syn)-labelled puncta that shows
positive (pos.) or no (neg.) staining for one or both of the other
proteins. More than 90% of puncta that are positive for the b2AR
and associated with synaptophysin are also positive for GluR1 (top
bar) and 480% of puncta that are positive for GluR1 and associated
with synaptophysin are also positive for the b2AR (second bar; a
total of 329 synapses in 15 fields in stratum radiatum 25–100mm
away from the pyramidal cell layer from three adult s.d. rats (five
fields per rat) were analysed). (C) Post-embedding immunogold
staining for the b2AR in PFC. (a) Three immunopositive axospinous
synapses in a single field. (b) A large strongly immunolabelled
synapse. Labelling is mainly over PSD, close to postsynaptic plasma
membrane (n¼ 2 brains). (D–F) GluR1, but not NMDARs, specifi-
cally co-immunoprecipitate with b2AR from rat brain lysates. Rat
brain was solubilized with 1% Triton X-100 and cleared by ultra-
centrifugation before immunoprecipitation (500mg protein per ly-
sate sample) with the H-20 antibody against b2AR or a control
antibody and immunoblotting with antibodies against proteins
indicated on the left side. The H-20 antibody, but not control IgG,
immunoprecipitated the b2AR (D; n¼ 3) and GluR1 (E; n¼ 6), but
not NR2B (E; n¼ 2). The b2AR did not co-precipitate with NMDARs
(F; n¼ 3; 25mg total lysate protein were loaded where indicated).
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targeting of AMPARs (Chen et al, 2000; Schnell et al, 2002).
Direct interactions between the b2AR with PSD-95 and star-
gazin with both PSD-95 and GluR1 could establish a physical
link between the b2AR and AMPARs (Figure 2C).
To test whether stargazin links the b2AR to GluR1 through
PSD-95 in neurons, we evaluated whether co-immunopreci-
pitation of GluR1 with the b2AR depends on the presence of
stargazin. Stargazer mice (stg/) lack functional stargazin,
the prevailing TARP in adult cerebellum (Chen et al, 2000;
Tomita et al, 2003; Menuz and Nicoll, 2008; Menuz et al,
2008). GluR1 co-immunoprecipitated with the b2AR from
cerebral cortex and cerebellum from wild-type mice
(Figure 2D, top left panel). In stg/ mice, GluR1 co-immu-
noprecipitated with the b2AR from cortex, but not from
cerebellum (Figure 2D, top right panel). These results indi-
cate a requirement for stargazin for association of the b2AR
with GluR1 in the cerebellum, but not cortex, consistent with
published evidence that other TARPs substitute for stargazin
in cortex.
As the b2AR forms a complex with GluR1, but not with
NMDAR, that depends on stg and PSD-95 and their homo-
logues, the interaction of the b2AR with PSD-95 or its homo-
logues is governed by other interactions of PSD-95. In other
words, it is controlled by the immediate molecular environ-
ment of PSD-95. That only certain combinations of binding
partners for complex formation with PSD-95 are realized in
vivo seems to be critical to avoid physiologically undesirable
assemblies or, worse, chaos by random complex formation.
b2AR–GluR1 complex also contains Gs and
adenylyl cyclase
Association of the b2AR with GluR1 could allow selective and
spatially restricted signalling. If so, the trimeric Gs protein,
adenylyl cyclase, and PKA must also be localized near GluR1.






















































































































































Figure 2 GluR1 forms a complex with the b2AR through PSD-95
and stargazin, which also contains Gs and adenylyl cyclase. (A) Rat
brains were extracted with 1% deoxycholate (left) and 1% Triton
X-100 (right) before immunoprecipitation with two different anti-
bodies against b2AR (H-20, M-20) or control IgG, followed by
immunoblotting with anti-PSD-95 (‘JH62092’ in Sans et al (2000);
n¼ 4). Specificity of the observed co-immunoprecipitation of
PSD-95 with b2AR (lanes 4,5,9,10) is indicated by a lack of
PSD-95 signal in the control IgG samples (lanes 3 and 8). (B) GST
fusion proteins of the PDZ1–2, PDZ2, PDZ3, SH3 and GK domains
of PSD-95 and GST alone were immobilized on glutathione
Sepharose and incubated with MBP fusion protein of the full
cytosolic C-terminus of the human b2AR (MBP-b2AR-CT) before
washing and immunoblotting with anti-MBP antibodies. MBP-b2AR-
CT bound strongly and specifically to the third PDZ domain (upper
panel lane 3), but not to other domains of PSD-95 or to GST alone
(lane 6). Reprobing with anti-GST antibodies shows that the differ-
ent GST fusion proteins were present in comparable amounts
(lower panel; n¼ 8). (C) Schematic illustration of the b2AR–GluR1
complex. Stg or one of its homologues in the AMPAR complex binds
with the C-terminus to the first two PDZ domains of PSD-95 or one
of its homologues. PSD-95 interacts with its third PDZ domain with
the C-terminus of the b2AR. (D) Loss of stargazin dissociates GluR1
from b2AR. Triton X-100 extracts of cortices and cerebella of
wild-type and litter-matched stargazer (Stg/) mice were cleared
by ultracentrifugation before immunoprecipitation of b2AR and
immunoblotting with anti-GluR1 antibodies. GluR1 co-immunopre-
cipitated with b2AR from both cortex and cerebellum of wild-type
mice (upper left panel) and with the b2AR from cortex, but not
cerebellum of stg/ mice (upper right panel). Lower panels
indicate that similar amounts of GluR1 were present in the various
extracts. Similar results were obtained in three independent experi-
ments with three wt and three stg/ mice. (E) Association of Gs
and adenylyl cyclase with the b2AR–AMPAR complex. Triton X-100
extracts of crude rat forebrain membrane fractions were cleared by
ultracentrifugation before immunoprecipitation with antibodies
against GluR1 (lane 1), b2AR (lane 2), or a non-specific control
IgG (lane 3), followed by immunoblotting for the proteins indicated
on the left side (Leonard et al, 1998; Davare et al, 2001). Anti-GluR1
and anti-b2AR precipitated PSD-95 (positive control, n¼ 3), adeny-
lyl cyclase (AC, n¼ 3), Gas (n¼ 3), and Gb. The latter was detected
with two different antibodies that recognized the N- (BN1; n¼ 2)
and C-termini (BC1; n¼ 3) of Gb14 (left panels). PKA (here the RIIa
subunit; n¼ 2) and Stg (n¼ 4) were also present in GluR1 and b2AR
precipitates. The metabotropic glutamate receptors mGluR1 (n¼ 3)
and mGluR5 (n¼ 3), caveolin 1(Cav1; n¼ 3) and the NMDA
receptor subunits NR2A (n¼ 1), NR2B (n¼ 3), and NR1 (n¼ 1)
did not co-immunoprecipitate with either GluR1 or b2AR (right
panels), although all proteins were clearly detectable in lysate (lane
4). All immunoprecipitations were made from lysate samples con-
taining 500 mg total protein; lysate aliquots containing 25mg protein
were loaded when indicated.
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the A kinase anchor protein, AKAP150 (Colledge et al, 2000;
Tavalin et al, 2002). AKAP150 associates with SAP97
(Colledge et al, 2000; Tavalin et al, 2002), which in turn
binds directly to the C-terminus of GluR1 (Leonard et al,
1998). Figure 2E illustrates that Gs and adenylyl cyclase are
also associated with GluR1: immunoprecipitation of either
GluR1 or the b2AR co-precipitated Gas, Gb, and adenylyl
cyclase in extracts from total forebrain (left upper panels)
as well as specifically from PFC and cerebellum
(Supplementary Figure 1A). PKA and stargazin also co-pre-
cipitated with GluR1 and the b2AR under these conditions
(Figure 2E, left lower panels) as did GluR2 as tested in PFC
and cerebellar extracts (Supplementary Figure 1A). As star-
gazin expression is low in forebrain (Tomita et al, 2003),
immunoreactive signals are low in lysate and immunopreci-
pitates from forebrain. In contrast to these proteins, several
other proteins that are likewise concentrated at the postsy-
naptic site did not co-immunoprecipitate with GluR1 or
the b2AR, including the metabotropic glutamate receptors
mGluR1 and mGluR5, and the NMDAR subunits NR1,
NR2A, and NR2B (Figure 2E, right panels). The plasma
membrane raft marker caveolin 1 was also absent in these
immunoprecipitates. Control IgG did not precipitate PSD-95,
adenylyl cyclase, Gas, Gb, PKA, and stargazin. Therefore, we
conclude that their co-immunoprecipitation with GluR1 and
the b2AR is specific.
Regulation of GluR1 S845 phosphorylation
by associated b2AR
By phosphorylating S845 on the intracellular COOH-terminal
region of GluR1 (Roche et al, 1996), PKA promotes activity-
driven synaptic targeting of GluR1 (Esteban et al, 2003). To
determine whether b2AR, Gs, adenylyl cyclase, PKA, and
GluR1 are organized into a functional complex, primary
hippocampal cultures were treated with the b-adrenergic
agonist isoproterenol (ISO; 3mM, 15 min). This treatment
increased phosphorylation of S845 of GluR1 in hippocampal
neurons (Figure 3A and B). The increase was attenuated with
the highly selective b2AR antagonist ICI118551 (1 mM), which
by itself reduced basal S845 phosphorylation in some, but not
all experiments. We next tested whether the b2AR–GluR1
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Figure 3 Localized regulation of GluR1 S845 phosphorylation by
the b2AR. Primary hippocampal cultures (18 DIV) were treated with
vehicle (VEH), 3 mM ISO, 10mM forskolin (FSK), or 10mM 1,9-
dideoxyforskolin (DDF; inactive forskolin homologue) for 15 min.
Cultures were extracted with Triton X-100 and cleared by ultracen-
trifugation. GluR1 was immunoprecipitated directly or after
pre-immunoprecipitation of b2AR complexes (H-20) before immu-
noblotting with antibodies against phosphorylated S845 (top) and
total GluR1 (bottom). Immunosignals were quantified by densito-
metry. Phospho-S845 (pS845) signals were corrected with respect to
total GluR1 signals and normalized to control. (A, B) ISO signifi-
cantly increased S845 phosphorylation. Pre-treatment for 15 min
with 1mM ICI118551-blocked ISO-induced phosphorylation. All
lanes are from same blot and exposure, but non-relevant lanes
have been removed between lane 3 and 4. (C–F) After treatments,
culture extracts were split into two equal portions. In contrast to the
total GluR1 population (left pairs in C, D), GluR1 remaining after
depletion of GluR1–b2AR complexes by pre-immunoprecipitation
with H-20 showed no ISO-induced increase in S845 phosphorylation
(right pairs in C, D), although forskolin stimulated S845 phosphor-
ylation in both the total and the GluR1–b2AR-depleted GluR1
populations (E, F). (G–J) Pre-treatment for 2 h with membrane-
permeant DSPL and ESDV peptides, but not their inactive analogues
DAPA and EADA (1 mM each) prevented induction of S845 phos-
phorylation by ISO. *Po0.05 compared with control treatments;
error bars: s.e.m.; n: number of independent experiments.
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dicted if signalling from the b2AR to the AMPAR through PKA
is localized. After treatment with vehicle or ISO and extrac-
tion with Triton X-100, each sample was divided into two
equal halves. One half was mock treated before immunopre-
cipitation of GluR1 to assess the total GluR1 population. The
other half was first depleted of GluR1 that was associated
with the b2AR by immunoprecipitation with anti-b2AR
antibody. The resulting supernatant lacking b2AR–GluR1
complexes was then used for immunoprecipitation with
anti-GluR1. As before, ISO treatment induced S845 phosphor-
ylation in the total GluR1 pool, but no such increase in
phosphorylation was observed for the GluR1 pool from
which b2AR-associated GluR1 had been removed (Figure 3C
and D). An analogous experiment with forskolin (10 mM,
15 min), a direct activator of adenylyl cyclase, led to in-
creased S845 phosphorylation in the total GluR1 as well as
the b2AR-depleted GluR1 populations (Figure 3E and F).
These results indicate that a substantial fraction of GluR1 is
available for phosphorylation by PKA on S845 on massive
stimulation of cAMP production even if not associated with
the b2AR. However, activation of the b2AR leads to selective
phosphorylation of b2AR-linked GluR1.
To further test whether the complex formation between
b2AR and GluR1 is necessary for efficient signalling, cultures
were pre-treated for 2 h with the membrane-permeable peptide
11R-QGRNSNTNDSPL (‘DSPL’). This peptide mimics the ex-
treme C-terminus of the b2AR, which interacts with the third
PDZ domain of PSD-95, and disrupts the co-immunoprecipita-
tion of the b2AR with GluR1 (Supplementary Figure 1B). It had
little effect on the co-immunoprecipitation of PSD-95 with
GluR1, as expected, because the latter engages PDZ domains
1 and 2 of PSD-95 and its homologues. Binding selectivities of
the first and second PDZ domains of PSD-95 and related
proteins such as SAP97 and SAP102 are very similar to each
other, but differ from those of the third PDZ domains (Lim et al,
2002, 2003). Control treatments were performed with its in-
active analogue 11R-QGRNSNTNDAPA (‘DAPA’) altered at the 0
and 2 position (in bold), which are critical for PDZ domain
binding. Subsequent incubation with ISO (3mM, 15 min) led to
increased S845 phosphorylation only in samples pre-treated
with DAPA, but not in those pre-treated with DSPL (Figure 3G
and H). A second pair of peptides gave analogous results:
11R-VYKKMPSIESDV (‘ESDV’) and its inactive analogue
11R-VYKKMPSIEADA (‘EADA’) is based on the C-terminus of
NR2A. ESDV has optimal binding affinity for PDZ1 and 2 of
PSD-95 and its homologues (Lim et al, 2002) and effectively
blocks PDZ1 and 2 interactions (Lim et al, 2003). The latter
conclusion had been based on immunoprecipitation experi-
ments of PSD-95 with the NMDAR and was now confirmed for
the co-immunoprecipitation of PSD-95 with GluR1, which was
disrupted as expected (Supplementary Figure 1B). Pre-treat-
ment with ESDV, but not EADA, prevented the ISO-triggered
increase in S845 phosphorylation (Figure 3I and J).
Collectively, these peptide experiments indicate that PSD-95
and its homologues structurally and functionally connect
through PDZ domains the b2AR to the GluR1–stargazin com-
plex for S845 phosphorylation.
Increased surface expression of GluR1
by the associated b2AR
The amount of GluR1 is increased at postsynaptic sites on
stimulation of S845 phosphorylation by PKA (Swayze et al,
2004; Sun et al, 2005; Man et al, 2007). We asked whether the
classic b-adrenergic signalling pathway controls postsynaptic
GluR1 accumulation in hippocampal neurons using ectopi-
cally expressed GluR1 with superecliptic pHluorin (SEP) at its
extracellular N-terminus. The pH-sensitive SEP–GluR1 signal
was nearly completely quenched if the extracellular pH was
lowered from 7.4 to 6.0 (Supplementary Figure 2), implying
that the SEP–GluR1 signal was only detectable if SEP–GluR1
was present at the surface, but not in acidic intracellular
organelles. The SEP–GluR1 fluorescence was stable for sev-
eral hours under our imaging paradigm (data not shown). In
initial experiments, 1 mM ISO in combination with the phos-
phodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX;
250 mM) to enhance cAMP levels on b-adrenergic stimulation
strongly increased surface expression of SEP–GluR1 at den-
dritic spines within 15 min, elevating both the intensity for
individual puncta and the number of detectable puncta per
dendritic length (Supplementary Figure 3). IBMX alone was
without effect indicating that signalling was driven by ISO.
The ISO effect was completely blocked if the b2AR antagonist
ICI118551 (1 mM) was added immediately before monitoring
SEP–GluR1 signals. Subsequent experiments illustrate that a
5 min treatment with 1 mM ISO is sufficient for the full
increase in synaptic SEP–GluR1 accumulation (Figure 4).
Similarly, ISO alone (10 mM, 15 min) elevated the number
and intensity of GluR1-positive puncta detected by surface
labelling of endogenous GluR1 with an antibody against its
N-terminus (Figure 5). Double labelling with the synaptic
marker synaptophysin confirmed that ISO-induced increases
in GluR1 staining occurred at synapses (Figure 5A, B, D, E).
This elevation was fully blocked by the b2AR antagonist
ICI118551, but not by the b1AR antagonist ICI89406
(Figure 5F; Supplementary Figure 4). Disrupting binding of
stargazin and its homologues to PDZ1 and 2 of PSD-95 and its
homologues with the ESDV peptide or of the b2AR to PDZ3 of
PSD-95 with the DSPL peptide also prevented ISO-induced
increases in GluR1 surface expression (Figure 5G; Supple-
mentary Figure 4). The corresponding control peptides EADA
and DAPA had no effect (Figure 5G). ICI118551 and more so
DSPL (but for unknown reasons not ESDV) showed a clear
tendency towards reducing GluR1 surface labelling under
control conditions by themselves, which reached statistical
significance for changes in synaptic GluR1 puncta frequency
(Figure 4D). These results suggest that basal activity of the
b2AR can enhance GluR1 surface expression under non-
stimulated conditions (see also effect of ESDV and DSPL on
EPSC in PFC below). At the same time, none of the peptides
affected the localization of the b2AR, PSD-95, or the NMDAR
under control conditions (Supplementary Figure 5). These
findings exclude a widespread basal effect of these peptides
and reassure that the actions of DSPL and ESDV on b2AR-
mediated effects are due to specific interference with the
b2AR–GluR1 assembly. We conclude that stimulation of the
b2AR promotes surface expression of GluR1 that resides in a
complex with the b2AR held together by PSD-95.
Stimulation of the b2AR up-regulates postsynaptic
AMPAR responses
Activation of bARs can modestly increase synaptic transmis-
sion at glutamatergic synapses in hippocampal slices within
minutes, although this increase varied and was not observed
in all recordings (Dahl and Sarvey, 1989; Thomas et al, 1996;
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Katsuki et al, 1997; Winder et al, 1999; Gelinas and Nguyen,
2005). Similarly, we found that 10mM ISO increased fEPSP
initial slope in acute hippocampal slices in 14 out of 23 slices
(Supplementary Figure 6A). Averaging all responses gave a
statistically significant increase by 24% (Supplementary
Figure 6B). Paired-pulse facilitation was unaltered, suggesting
that ISO acted postsynaptically (Supplementary Figure 6C).
As ISO-induced up-regulation of fEPSPs was variable in
hippocampal slices, we evaluated its effect in the PFC, which
receives stronger noradrenergic innervation than the hippo-
campus (Minzenberg et al, 2008). In acute PFC slices, 10 mM
ISO caused a robust and lasting increase of EPSC amplitudes
by 450% (Figure 6A), which was completely blocked by
the b2AR antagonist ICI118551 (Figure 6B). ICI118551 itself
reduced EPSC amplitude by 14.4±2.6% (not illustrated),
presumably reflecting basal b2AR activity. Paired-pulse facil-
itation was unaltered in PFC slices (Figure 6C), indicating
that the ISO effects were postsynaptic. ISO also significantly
increased mEPSC amplitude (Figure 6D and E), but had no
effect on mEPSC frequency (Figure 6E), decay time constant
(control: 4.7±0.5 ms; n¼ 6; ISO: 4.8±0.32 ms; n¼ 5; wash:
4.7±0.36 ms; n¼ 5), or the 10–90% rise time (control: 2.7±
0.05 ms; n¼ 6; ISO: 2.7±0.05 ms; n¼ 5; wash: 2.8±0.07 ms;
n¼ 5). As the ISO effect was more robust and predictable in
Figure 4 ISO increases SEP–GluR1 surface expression in dendritic spines. Primary hippocampal cultures were transfected with SEP–GluR1 at
5–7 DIV and imaged at 21DIV. ISO (1 mM) increased density and signal intensity of SEP–GluR1 puncta within 5 min, which otherwise remained
constant under untreated control conditions. *Po0.05 compared with control; error bars: SEM. In each case, a minimum of 5 dendrites from 15
neurons in 3 different experiments were analysed.
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PFC than hippocampus slices, we used the PFC for further
mechanistic studies.
Up-regulation of AMPAR responses in PFC
by the b2AR depends on PKA
To ensure that the ISO response is mediated by PKA, the
highly specific PKA inhibitory PKI peptide PKI522 was
included in the patch pipette for both evoked EPSC and
mEPSC analysis. Dialysis of PKI522 (40 mM) gradually re-
duced AMPAR-EPSC by 30.7±4.4% (n¼ 9) and blocked the
increasing effect of ISO (10.1±3.9%; n¼ 9; Figure 6F;
Supplementary Figure 7A). A scrambled control peptide had
no effect on EPSC (5.8±1.5%; n¼ 5), and the ISO effect
remained intact (51.6±3.5%; n¼ 5).
Dialysis of PKI522, but not scrambled peptide, also
reduced mEPSC amplitude (control: 14.4±0.8pA; n¼ 8;
PKI522: 10.2±0.8pA; n¼ 8; scrambled peptide: 13.8±
0.6pA; n¼ 6; Figure 6G; Supplementary Figure 7C and E),
but not frequency (control: 3.9±0.4 Hz; n¼ 8; PKI522:
3.8±0.4 Hz; n¼ 8; scrambled peptide: 3.3±0.4 Hz; n¼ 6;
Supplementary Figure 7D and F). PKI522 abolished the
increasing effect of ISO on mEPSC amplitude (PKI522:
10.2±0.8pA; n¼ 8; PKI522þ ISO: 11.6±0.9pA; n¼ 8;
Supplementary Figure 7E), whereas the effect was intact in
scrambled peptide-injected neurons (scrambled peptide:
13.8±0.6pA; n¼ 6; scrambled peptideþ ISO: 19.3±0.9pA;
n¼ 7, Po0.001, ANOVA). ISO had also no effect on mEPSC
frequency in the presence of PKI522 (PKI522: 3.8±0.4 Hz;
Figure 5 GluR1-associated b2AR stimulates surface expression of endogenous GluR1. (A, B) Primary hippocampal cultures (18 DIV) were
treated with vehicle (VEH) or 10mM ISO for 15 min, surface labelled with the N-terminal GluR1 antibody (red), fixed, permeabilized, and
counter labelled with anti-synaptophysin antibody (green). ISO caused a significant increase in surface expression of GluR1 compared with
control cells treated with vehicle as indicated by quantification of total density of GluR1 puncta (C), density of synaptic GluR1 puncta (D;
puncta that are colocalized with synaptophysin puncta), and GluR1 staining intensity at synaptic puncta (E). The ISO effect was blocked by
15 min pre-treatment with the b2AR-selective antagonist ICI118551 (1 mM), but not the b1AR-selective antagonist ICI89406 (1 mM; F). (G) Pre-
treatment for 1 h with membrane-permeant DSPL and ESDV peptides, but not their inactive analogues DAPA and EADA prevented ISO from
increasing GluR1 surface expression. *Po0.05; **Po0.001; ***Po0.0001 compared with controls treatments or as indicated; error bars:
s.e.m.; n: number of neurons analysed in at least three independent experiments for each condition.
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n¼ 8; PKI522þ ISO: 3.9±0.41 Hz; n¼ 8) or scrambled pep-
tide (scrambled peptide: 3.3±0.4 Hz; n¼ 6; scrambled
peptideþ ISO: 3.4±0.16 Hz; n¼ 7).
ISO induces a lasting increase in S845 phosphorylation
through adenylyl cyclase
As the increase in EPSC and mEPSC amplitude by ISO in PFC
remained beyond washout of ISO, we tested whether the
same would be true for S845 phosphorylation. Incubation of
acute PFC slices with 10mM ISO lead to near maximal
phosphorylation within 2 min (Supplementary Figure 8).
Importantly, when slices were treated for 15 min with ISO
followed by 15 min washout of ISO S845, phosphorylation
remained elevated, which explains the continued heightened
EPSC and mEPSC responses after removal of ISO.
To corroborate that ISO acts through adenylyl cyclase,
which is part of the main signalling pathway downstream
of the b2AR and is present in the GluR1–b2AR complex
(Figure 2E; Supplementary Figure 1A), PFC slices were
treated with 10mM ISO for 15 min in the absence and pre-
sence of 20mM SQ22536, an adenylyl cyclase inhibitor. The
increase in S845 phosphorylation by ISO was reduced by
450%, indicating that it was largely mediated by adenylyl
cyclase (not illustrated).
Figure 6 b2AR stimulation increases postsynaptic AMPAR-mediated EPSCs in PFC slices. (A) During bath application of ISO (10mM; grey
symbols), the amplitude of evoked AMPAR-EPSC in PFC pyramidal neurons gradually increased by 53±7.7% (n¼ 7), lasting for at least 20 min
(after 20 min washout: 71.4±23.7%; n¼ 7). (B) Bath application of the b2AR antagonist ICI118551 (1mM) prevented the ISO-triggered increase
in AMPAR-EPSC amplitude (109.5±1.8% of control, n¼ 12), compared with control cells without the antagonist (149.4±4.3%, n¼ 11).
(C) Paired-pulse facilitation (PPF) is unchanged in neurons treated for 15 min with 10 mM ISO (20 ms interval: control: 2.08±0.1, ISO:
2.14±0.1; n¼ 5; 50 ms interval: control: 1.6±0.06, ISO: 1.6±0.06; n¼ 7; paired-pulse ratio was determined by dividing the amplitude of the
second EPSC to the first EPSC). (D, E) Miniature EPSC (mEPSC) recordings from PFC slices. Bath perfusion of ISO (10mM, 15 min) increased
mEPSC amplitude by 28.6±2.7% (from 13.8±0.7 pA to 18.0±1.4 pA; n¼ 6), which remained elevated for at least 20 min (after 20 min
washout: 27±2.3%; n¼ 6). However, there was no significant change for mEPSC frequency (before ISO: 3.1±0.35 Hz; with ISO: 3.3±0.3 Hz;
n¼ 9). (F, G) PKA is required for up-regulation of AMPAR responses by ISO. Injection of PKI522, but not scrambled peptide (40 mM) inhibited
EPSC (F) and mEPSC amplitudes (G) and prevented ISO from increasing the amplitudes.
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Up-regulation of AMPAR responses by ISO requires
b2AR–AMPAR association
The DSPL and ESDV peptides were used to test whether up-
regulation of AMPAR-mediated EPSCs by the b2AR depends
on PSD-95 binding to TARPs and the b2AR. Infusion of either
peptide through the whole-cell recording electrode prevented
ISO from increasing EPSCs (Figure 7). Similar to ICI118551,
both peptides decreased EPSC amplitude by themselves,
further supporting the notion that basal activity of GluR1-
associated b2AR enhances AMPAR responses under resting
conditions in PFC slices. The corresponding control peptides
(DAPA and EADA) showed none of these effects.
Up-regulation of AMPAR responses by the b2AR
depends on intact exocytosis
Phosphorylation of S845 up-regulates GluR1 surface
expression by promoting its insertion into the plasma
membrane (Ehlers, 2000; Swayze et al, 2004; Sun et al,
2005; Oh et al, 2006; Man et al, 2007). It also might increase
AMPAR channel activity (Roche et al, 1996). To evaluate
whether the b2AR up-regulates AMPAR responses mainly
by augmenting surface expression, we used two different
reagents that inhibit exocytosis. N-ethylmaleimide (NEM)
inhibits NEM-sensitive factor, and thereby membrane
fusion events required for trafficking of surface proteins to
the plasma membrane. Earlier work established that post-
synaptic injection of NEM blocks LTP without affecting basal
postsynaptic responses (Lledo et al, 1998). Similarly, NEM
infusion did not alter EPSCs in PFC neurons under basal
conditions, but prevented up-regulation of EPSCs by ISO
(Figure 8A and C). Botulinum neurotoxin B (BoTox) and
tetanus toxin (TeTox) block exocytosis by proteolytic cleavage
of synaptobrevin/VAMP2, which is critical for exocytosis
(Schiavo et al, 2000). Injection of the catalytically active
BoTox or TeTox light chain does not reduce basal postsynaptic
responses, but abrogates LTP (Lledo et al, 1998; Lu et al,
2001). Similar to NEM, BoTox blocked the ISO-triggered
increase in EPSC amplitude (Figure 8B and C). These
data show that ISO increases postsynaptic AMPAR responses
mainly by promoting insertion of AMPARs into the
cell surface.
Discussion
Our data indicate that the b2AR, Gs, and adenylyl cyclase
form a supramolecular signalling complex with GluR1, which
is known to associate with PKA and the antagonistic phos-
phatase PP2B through AKAP150, SAP97, and, alternatively,
PSD-95 (Leonard et al, 1998; Colledge et al, 2000; Tavalin
et al, 2002). Remarkably, only GluR1-containing complexes
that are associated with b2ARs are effectively regulated by
b-adrenergic stimulation, showing that this assembly
Figure 7 Peptides that disrupt the b2AR–AMPAR interaction specifically prevent the ISO-induced increase in EPSCs amplitude in PFC slices.
(A–C) Basal AMPAR-EPSC amplitudes were significantly reduced by injection of the DSPL peptide (50mM) by 25.2±4.9% (n¼ 5), but not by
the control DAPA peptide (50 mM; 3.2±2.2% reduction; n¼ 5). DSPL diminished the ISO response to an increase of 15.7±5.9% (n¼ 7), but
DAPA did not cause any significant reduction (increase was 54.3±6.6%; n¼ 6). (D–F) Basal AMPAR-EPSC amplitudes were significantly
reduced by injection of the ESDV peptide (50mM) by 37.5±4% (n¼ 10), but not by the control EADA peptide (50mM; 8.8±4.7% reduction;
n¼ 10). ESDV diminished the ISO response to an increase of 6.8±2.7% (n¼ 10), but DAPA did not cause any significant reduction (increase
was 62.7±12.9%; n¼ 10).
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allows for highly localized control of GluR1 phosphorylation
by the b2AR.
Another study suggests that the b1AR, but not b2AR,
regulates S845 phosphorylation (Vanhoose and Winder,
2003), contrasting our findings. The differences between
this and our study that lead to this discrepancy outcome
could be related to differences in the exact experimental
system, though quite similar, or the high concentrations of
the b1 selective blocker betaxolol (10 mM) used in the other
study at which isotype specificity could have been lost (e.g.
Smith and Teitler, 1999; Sharif and Xu, 2004). In addition,
there was no evidence presented that the ICI118551 batch was
active in the other study. However, we do not want to exclude
that the b1AR can contribute to S845 phosphorylation under
certain conditions.
Phosphorylation of S845 by PKA promotes GluR1 surface
expression because of a combination of reduced internaliza-
tion rate and increased re-insertion rate (Ehlers, 2000; Man
et al, 2007). We now show that, upstream of PKA, activation
of the b2AR specifically augments the synaptic expression of
GluR1. S845 phosphorylation might also enhance the activity
of GluR1-containing AMPARs by increasing their open prob-
ability (Banke et al, 2000), which could have contributed to
the increase in AMPAR responses we observed in acute
hippocampal and PFC slices. However, ISO-induced increases
in the PFC were largely blocked by infusion of BoTox indicat-
ing that increased activity of AMPARs that were already
present at postsynaptic sites could have made only a modest
contribution.
The increase in GluR1 surface expression contrasts with
the decrease of b2AR typically induced by b2AR ligands.
However, agonist-induced internalization typically reduces
surface b2AR by o50%, and in some cases as little as 10%
(e.g. Shenoy et al, 2006). Furthermore, association of the
b1AR with PSD-95 inhibits its ligand-induced internalization
(Xu et al, 2001). Analogously, the b2AR might be resistant to
internalization when forming a complex with PSD-95, star-
gazin, and GluR1.
The b2AR-dependent increase in S845 phosphorylation
emerges as an important consequence of adrenergic activa-
tion throughout the brain. b-adrenergic stimulation can in-
crease synaptic transmission at glutamatergic synapses in
hippocampal slices within minutes, although that is not
observed in all experiments (Dahl and Sarvey, 1989;
Thomas et al, 1996; Katsuki et al, 1997; Winder et al, 1999;
Gelinas and Nguyen, 2005). At the same time, b-adrenergic
activation fosters induction of LTP, which can transform a
reversible increase in synaptic strength into a lasting one
(Thomas et al, 1996; Katsuki et al, 1997; Winder et al, 1999;
Lin et al, 2003; Gelinas and Nguyen, 2005). Recent work
indicates that norepinephrine and emotional stress induce
phosphorylation of GluR1 S845 and to a lesser degree on
S831, a phosphorylation site for PKC and CaMKII (Hu et al,
2007). Mutating both sites to alanine interferes with norepi-
nephrine-dependent LTP induction by a 10 Hz/90 s tetanus
and fear conditioning by a modest conditioning paradigm (Hu
et al, 2007). Furthermore, a single mutation of S845 to
alanine prevents ISO from priming neurons in the visual
cortex for spike time-dependent potentiation (Seol et al,
2007).
In closing, the localized signalling from the b2AR to GluR1
described here represents a critical regulatory mechanism for
postsynaptic functions linking the noradrenergic and gluta-
matergic systems in the brain. This mechanism is likely to
have a major function in mediating noradrenergic effects on
the brain, including heightened arousal and facilitation of
synaptic plasticity and learning (Cahill et al, 1994; Nielson
and Jensen, 1994; Berman and Dudai, 2001; Strange et al,
2003; Strange and Dolan, 2004; Hu et al, 2007). These find-
ings also illustrate the importance of noradrenergic inner
vation of the hippocampus, although this innervation is
typically eliminated in experiments using hippocampal slices,
but must not be neglected. Finally, the characterization of the
b2AR–Gs–adenylyl cyclase–PKA–GluR1 complex reported
here illuminates the capability of the b2AR to drive spatially
restricted generation of cAMP. This work firmly establishes
the concept of locally restricted and thereby highly selective




ISO, ICI118551, forskolin, dideoxyforskolin, and NEM were from
Sigma and ICI89406 from Biotrend Chemicals Inc. A peptide derived
from the C-terminus of GluR1 (MSHSSGMPLGATGL) was purified
by HPLC, cross-linked with glutaraldehyde to bovine serum
albumin and injected into rabbits as described (Davare et al,
1999) to obtain anti-GluR1 antiserum. For immunoprecipitation of
Figure 8 Exocytosis blockage prevents the ISO-induced increase in EPSCs amplitude in PFC slices. (A) Dialysis of NEM (5 mM) itself did not
significantly alter AMPAR-EPSC amplitude (104.3±1.4% of control; n¼ 11), but decreased the effect of ISO to an increase of 11.8±2.6%
stimulation (n¼ 11). (B) Dialysis of Botulinum neurotoxin (0.5 mM) itself did not significantly alter AMPAR-EPSC amplitude (102.8±1.5%;
n¼ 8), but reduced the effect of ISO to an increase of 10±1.9% stimulation (n¼ 10). (C) Averages in changes of EPSC amplitudes from all
experiments from panels A and B.
A b2AR–AMPA receptor signalling complex
M-lA Joiner et al
&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 2 | 2010 491
GluR1, 2ml of this serum were used in 0.5 ml extracts. For
immunoblotting, this serum was diluted 1:1000. Antibodies against
the extracellular N-terminus of GluR1 were from Oncogen Research,
Bassoon from Stressgen, b2AR (H-20 and M-20) from Santa Cruz,
and Gas from Upstate. Non-specific rabbit IgG was from Zymed.
Anti-PSD-95 was produced earlier by us and corresponds to
‘JH62092’ in Leonard and Hell (1997), Leonard et al (1999), Sans
et al (2000), and Davare et al (2001). All other antibodies including
those against Gb, pan-adenylyl cyclase, mGluR1, mGluR5, caveolin-
1, NR1, NR2A, and NR2B and the phospho-specific antibody against
S845 were as described earlier (Leonard and Hell, 1997; Leonard
et al, 1999; Sans et al, 2000; Davare et al, 2001; Lu et al, 2007). The
membrane-permeable peptides 11R-QGRNSNTNDSPL (DSPL), 11R-
QGRNSNTNDAPA (DAPA), 11R-VYKKMPSIESDV (ESDV), and 11R-
VYKKMPSIEADA (EADA) were custom synthesized by the W. M.
Keck Biotechnology Resource Center, Yale University and HPLC
purified. Botulinum Neurotoxin Type B Light Chain (BoTox) was
from Listlabs. All other reagents were from the usual suppliers and
of standard quality.
Immunocytochemistry
Adult male Sprague–Dawley rats were deeply anesthetized with
sodium pentobarbital and perfused with 4% paraformaldehyde
following NIH guidelines as described (Burette et al, 1999) and
approved by the University of North Carolina. Fifteen minutes after
the onset of fixation, material was flushed with normal saline.
Brains were removed, tissue sections cut on a Vibratome and
processed for multiple label immunofluorescence. After blocking,
rabbit anti-b2AR (1:10000; H-20) was added, followed by horse-
radish peroxidase-conjugated secondary antibody. Fluorophore-
conjugated tyramide was then used to amplify the signal followed
by PBS washes (Burette et al, 1999). Subsequently, standard double
labelling with rabbit anti-GluR1 antibody (1:1000) and mouse-anti-
synaptophysin (1:5000) was performed. Quantitative data were
collected by confocal microscopy from stratum radiatum of
hippocampal CA1, at least 25 mm from the pyramidal layer (Melone
et al, 2005); 329 synapses from five fields from each of three rats
were analysed for quantification of the number of b2AR- and GluR1-
labelled puncta (Melone et al, 2005). We considered only neuropil,
avoiding somata and dendritic shafts. To focus specifically on
synaptic labelling, we only considered immunopositive puncta
clearly associated with puncta stained for synaptophysin.
Immunogold labelling
Pentobarbital-anesthetized adult rats were perfused with a mixture
of 2% depolymerized paraformaldehyde and 2% glutaraldehyde in
phosphate buffer, after a brief saline rinse, as per institutionally
approved protocols and NIH guidelines. A total of 200 mm
Vibratome sections were cryoprotected in 30% glycerol. Chunks
of prefrontal/orbital cortex were plunge frozen in isopentane and
dehydrated over several days at 601 in ethanol with 1% uranyl
acetate, infiltrated with Lowicryl HM-20, and UV-polymerized at
low temperature. Thin (B80–100 nm) sections were collected on
nickel mesh grids and processed for immunogold labelling, using
the M20 antibody at 1:1000 dilution, according to Phend et al (1992,
1995). Grids were examined on a Philips Tecnai transmission
electron microscope.
Immunoprecipitation and immunoblotting
Sprague–Dawley rats were obtained from Harlan and homozygous
stargazer mice and litter-matched wild-type control mice from
Jackson Laboratories. The Animal Care and Use Committee of the
University of Iowa approved all procedures involving animals.
Forebrains, neocortices, or cerebella were homogenized in a 10-fold
volume of Buffer A (150 mM NaCl, 10 mM EDTA, 10 mM EGTA,
10 mM Tris–HCl, pH 7.4, and protease inhibitors) containing 1%
deoxycholate or 1% Triton X-100, and cleared from non-solubilized
material by ultracentrifugation (minimally 250 000 g for 30 min)
before immunoprecipitation with the C-terminal GluR1 antibody,
H20 against the b2AR, or an equivalent amount of non-specific
rabbit IgG and subsequent immunoblotting with the indicated
antibodies as described (Leonard and Hell, 1997; Leonard et al,
1999).
GST and MBP fusion proteins and pull-down assay
GST fusion proteins of the PDZ1–2 (residues 1–185), PDZ2 (156–
248), PDZ3 (302–402), SH3 (431–500), and GK (534–724) domains
of PSD-95 and an MBP fusion protein of the full cytosolic
C-terminus of the human b2AR (MBP-b2AR-CT; residues 326–413)
were expressed in Escherichia coli as described (Seabold et al,
2003). GST fusion proteins were bound to glutathione Sepharose 4B
(Amersham), washed, incubated with MBP-b2AR-CT for 90–
120 min at 41C in TBS (10 mM Tris, 150 mM NaCl, 0.1% TX100;
pH 7.4), and washed. Immunoblotting was performed with
a monoclonal anti-MBP antibody (NEB), stripped with SDS
and dithiothreitol and reprobed with anti-GST antibody (Leonard
et al, 1998).
Hippocampal cultures and phosphorylation studies
Hippocampal cultures were prepared from E18 embryonic Sprague–
Dawley rats (Harlan) and maintained as described (Lim et al, 2003)
using the B27-derived culture medium supplement NS21 (Chen
et al, 2008). Cultures (DIV18) were pre-incubated for 15 min with
the bAR antagonists ICI118551 (b2AR; 1mM) or ICI 89406 (b1AR;
1mM) if indicated before incubation with vehicle (water) versus
ISO (1–3 mM) or forskolin (10mM; from DMSO stock) versus
1,9-dideoxyforskolin (10mM) for 15 min. For immunoprecipitation
and analysis of S845, phosphorylation cultures were extracted
with Triton X-100 in Buffer A containing the phosphatase inhibitors
microcystin (0.4mM) and para-nitriphenyl phosphate (100 mM).
GluR1 was either directly immunoprecipitated or immuno-
precipitated after initial immunoprecipitation with H-20 to remove
GluR1–b2AR complexes before subsequent immunoblotting with
antibodies against GluR1 phosphorylated at S845 and, after
stripping, with the C-terminal GluR1 antiserum. Relative phosphor-
ylation levels were determined by densitometry of ECL signals on
film. After scanning, pixel intensity of bands was quantified using
Adobe Photoshop. Signals were in the linear range as shown earlier
(Davare and Hell, 2003; Hall et al, 2006). Values were corrected for
any variation in total GluR1 loaded and normalized to control
treatment.
GluR1 surface labelling in hippocampal cultures
For surface labelling of GluR1, cultures were incubated after drug
treatments with the N-terminal GluR1 antibody for 20 min at 371C,
fixed with 4% paraformaldehyde and 4 % sucrose for 15 min at
room temperature, and incubated with Alexa 568 anti-rabbit
secondary antibody (Molecular Probes) for 1 h at room temperature
under non-permeabilized conditions (Swayze et al, 2004; Lise et al,
2006). For double labelling of GluR1 surface stained cultures,
neurons were permeabilized with cold methanol for 5 min and
incubated with anti-synaptophysin antibody overnight, followed by
incubation with the appropriate secondary antibody. Images were
taken using a  63 objective on a Zeiss Axiovert M200 microscope.
To allow comparison between different specimens, pictures were
taken under the same settings. To correct for out-of-focus clusters
within the field of view, focal plane (z) stacks were acquired and
maximum intensity projections performed offline. Images were
scaled to 16 bits and analysed in Northern Eclipse (Empix Imaging,
Mississauga, Canada), by using user-written software routines
(Gerrow et al, 2006; Lise et al, 2006). To measure puncta intensity
and number per dendrite length, an experimenter blind to the
treatment conditions manually outlined dendrites (at least 300 mM).
Puncta were defined as sites of intensity at least twice the
background. Average integrated puncta intensity was obtained by
subtracting the average background grey from the average puncta
grey intensities, which was then multiplied by the average puncta
area. GluR1 puncta colocalizing with synaptophysin puncta were
considered synaptic. At least eight neurons from two to three
independent experiments were analysed. The s.e.m. values were
calculated based on number of neurons examined. Two-tailed
parametric Student’s t-tests were performed to calculate the
statistical significance of differences between two groups; one-
way ANOVA was used to compare three or more groups, followed
by Tukey-b post hoc analysis for multiple comparisons.
Monitoring SEP–GluR1 surface expression in hippocampal
cultures
SEP was kindly provided by Dr Gero Miesenbock (Yale University,
New Haven, CT). Its coding sequence was amplified by PCR
(QuikChange protocol; Stratagene, La Jolla, CA) and inserted into
the N-terminus of rat GluR1 after a signal peptide in pRK5 vector.
Rat hippocampal cultures (DIV 5–7) were co-transfected with
plasmids encoding DsRed (used to find transfeceted cells not to
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bleach GFP) and SEP–GluR1 by the calcium phosphate method.
At DIV 21, live cell images were captured with a system consisting
of a BD CARVIITM confocal imager connected to a Leica DMIRE2
fluorescence microscope and a Hamamatsu EM CCD camera with
filter sets. The X-Y coordinates of individual neurons on a
mechanical X-Y stage were recorded within the IPLab4 software
program, so that the same neuron could be located and
photographed at different time periods during treatment. To
maintain the neuron viability, imaging was carried out with a
temperature-controlled stage (371C) fitted with a CO2 chamber set
at 5% (Leica Microsystems). After capturing an image, the culture
dish was immediately put back to a humidified 5% CO2 incubator at
371C for prolonged treatment.
Stacks of confocal images (not 425 z-planes) at 0.5 mm intervals
were merged into one single image before analyses. All digital
images were analysed with IPLab4 software (BD Biosciences). SEP–
GluR1 puncta were defined as either dendritic protrusions with
expanded heads that were 50% wider than their necks or regions of
intensity at least twice the dendritic intensity. To quantify the SEP–
GluR1 and dendritic intensity, the outline of puncta and the middle
line on dendrites were manually drawn and these parameters were
measured using the IPlab4 software. Average blank field intensity
used as background was subtracted from these measurements to
yield the actual intensity of SEP–GluR1. Data are expressed as
mean±s.e.m. of the indicated number of experiments. Statistical
significance was determined using a paired t-test (Sigma plot 7.0;
Systat software, San Jose, CA) in comparing the puncta density
and fluorescence intensity before and after treatment of the same
neuron.
Electrophysiological recording from PFC slices
All experiments were carried out with the approval of State
University of New York at Buffalo Animal Care Committee following
NIH guidelines. Slices were prepared from 3–5-week-old Sprague–
Dawley rats as described before (for details see, Wu et al, 2005). In
brief, animals were anesthetized by inhaling 2-bromo-2-chloro-
1,1,1-trifluoroethane (1 ml/100g; Sigma) and decapitated. Brains
were quickly removed and sliced (300mm) with a Leica VP1000S
Vibratome, whereas bathed in HEPES-buffered salt solution. Slices
were then incubated for 1–5 h at room temperature (22–241C) in a
NaHCO3-buffered saline (EBSS) bubbled with 95% O2, 5% CO2.
AMPAR-mediated synaptic transmission was monitored by
standard whole-cell patch recordings from pyramidal neurons
located in layer V in PFC slices (Yuen et al, 2007). PFC slices were
perfused with oxygenated artificial cerebro-spinal fluid (ACSF)
containing (mM) NaCl (130), NaHCO3 (26), CaCl2 (1), MgCl2 (5),
KCl (3), glucose (10), NaH2PO4 (1.25) plus GABAAR antagonist
bicuculline (10mM) and NMDAR antagonist D-aminophosphonova-
lerate (APV, 25mM). Patch pipettes (5–8 MO) were filled with
internal solution containing (mM) Cs-methanesulfonate (130), CsCl
(10), NaCl (4), MgCl2 (1), HEPES (10), EGTA (5), QX-314 (2.2),
phosphocreatine (12), MgATP (5), Na2GTP (0.5), and leupeptin
(0.1); pH 7.2–7.3, 265–270 mOsm. Neurons were observed with a
 40 water-immersion lens and illuminated with near infrared (IR)
light, and the image was captured with an IR-sensitive CCD camera.
Recordings were performed using a Multiclamp 700A amplifier
(Axon Instruments). Tight seals (2–10 GO) were obtained by
applying negative pressure. The membrane was ruptured with
additional suction to obtain whole-cell configuration. Access
resistance (13–18 MO) was compensated by 50–70%. Neurons
were held at 70 mV. EPSCs were evoked by stimulating the
neighbouring neurons (50 ms pulse) with a bipolar tungsten
electrode (FHC, Inc.). To record mEPSC in PFC slices, slices were
perfused with a modified ACSF containing a low concentration of
MgCl2 (1 mM) and TTX (1mM). Data analysis was performed with
Clampfit (Axon Instruments). Spontaneous synaptic events were
analysed with Mini Analysis Program (Synaptosoft, Leonia, NJ).
Statistical comparisons of the amplitude and frequency of mEPSC
were made using the Kolmogorov–Smirnov test.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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